Dataset Information


A 7-month inhalation toxicology study in C57BL/6 mice demonstrates reduced pulmonary inflammation and emphysema following smoking cessation or switching to e-vapor products.

ABSTRACT: Cigarette smoking causes serious diseases, including lung cancer, heart disease, and emphysema. While cessation remains the most effective approach to minimize smoking-related disease, alternative non-combustible tobacco-derived nicotine containing products may reduce disease risks among those unable or unwilling to quit. E-vapor aerosols typically contain significantly lower levels of smoke-related harmful and potentially harmful constituents; however, health risks of long-term inhalation exposures are unknown. We designed a 7-month inhalation study in C57BL/6 mice to evaluate long-term respiratory toxicity of e-vapor aerosols compared to cigarette smoke and to assess the impact of smoking cessation or switching to an e-vapor product after 3 months of exposure to 3R4F cigarette smoke (CS). There were no significant changes in in-life observations (body weights, clinical signs) in e-vapor groups compared to the Sham Control. The 3R4F CS group showed reduced respiratory function during exposure and had lower body weight and showed transient signs of distress post-exposure. Following 7 months of exposure, e-vapor aerosols resulted in no or minimal increase in pulmonary inflammation, while exposure to 3R4F CS led to impairment of lung function and caused marked lung inflammation and emphysematous changes. Biological changes observed in the Switching group were similar to the Cessation group. 3R4F CS exposure dysregulated lung and nasal tissue transcriptome, while these molecular effects were substantially lower in the e-vapor group. Results from this study demonstrate that in comparison with 3R4F CS, e-vapor aerosols induce substantially lower biological responses including pulmonary inflammation and emphysema, and that complete switching from CS to e-vapor products significantly reduces biological changes associated with cigarette smoke in C57BL/6 mice.

SUBMITTER: Yang Xiang 

PROVIDER: E-MTAB-9597 | BioStudies | 2021-03-18

REPOSITORIES: biostudies

Similar Datasets

2021-03-18 | E-MTAB-9597 | ArrayExpress
2021-03-31 | PXD019918 | Pride
2018-02-09 | E-MTAB-6471 | BioStudies
2021-08-16 | E-MTAB-7980 | ArrayExpress
2021-08-16 | E-MTAB-7981 | ArrayExpress
2021-01-31 | E-MTAB-10071 | BioStudies
2021-02-28 | E-MTAB-10166 | BioStudies
2018-02-09 | E-MTAB-6471 | ArrayExpress
2016-01-01 | S-EPMC4725611 | BioStudies
2020-01-01 | S-EPMC7303066 | BioStudies